Company Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Edwards Lifesciences Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:43:17 2023-12-07 pm EST			5-day change	1st Jan Change
67.38 ^USD	-3.04%		-0.53%	-9.73%

04:52pm	Edwards Lifesciences Sets 2024 Guidance, Outlines Plan to Spin Off Critical Care; Stock Buyback Boosted	MT
02:37pm	Edwards Lifesciences Corporation (NYSE:EW) announces an Equity Buyback for $1,000 million worth of its shares.	CI

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:

- hemodynamic monitoring systems (65.4%);

- heart valves and surgery products (18.7%);

- other (15.9%): balloon catheters, artificial implants, etc.

Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).

Number of employees : 17,300

USD in Million	2021	Weight	2022	Weight	Delta
Transcatheter Aortic Valve Replacement 65.4 %	3,423	65.4 %	3,518	65.4 %	+2.80%
Surgical Structural Heart 16.6 %	889	17.0 %	893	16.6 %	+0.45%
Critical Care 15.9 %	835	16.0 %	855	15.9 %	+2.41%
Transcatheter Mitral and Tricuspid Therapies 2.2 %	86	1.6 %	116	2.2 %	+35.00%

USD in Million	2021	Weight	2022	Weight	Delta
United States 58.2 %	2,963	56.6 %	3,133	58.2 %	+5.72%
Europe 21.8 %	1,190	22.7 %	1,175	21.8 %	-1.30%
Rest of World 11.2 %	550	10.5 %	601	11.2 %	+9.31%
Japan 8.8 %	529	10.1 %	474	8.8 %	-10.46%

Managers	Title	Age	Since
Bernard Zovighian CEO	Chief Executive Officer	56	2014
Scott Ullem DFI	Director of Finance/CFO	56	2013
Michael Mussallem CHM	Chairman	70	1999
Todd Brinton CTO	Chief Tech/Sci/R&D Officer	-	2019
Mark A. Wilterding IRC	Investor Relations Contact	-	-
Linda J. Park LAW	General Counsel	45	-
Jean-Luc Lemercier PRN	Corporate Officer/Principal	64	2017
Tammy Perry PRN	Corporate Officer/Principal	-	2011
Donald E. Bobo PRN	Corporate Officer/Principal	61	1994
Catherine Szyman PRN	Corporate Officer/Principal	56	2014

Members of the board	Title	Age	Since
Leslie Heisz BRD	Director/Board Member	62	2016
Nicholas Valeriani BRD	Director/Board Member	66	2014
Steven Loranger BRD	Director/Board Member	71	2016
Michael Mussallem CHM	Chairman	70	1999
Paul LaViolette BRD	Director/Board Member	65	2020
Kieran Gallahue BRD	Director/Board Member	59	2015
Martha H. Marsh BRD	Director/Board Member	74	2015
Ramona Sequeira BRD	Director/Board Member	57	2020
Bernard Zovighian CEO	Chief Executive Officer	56	2014

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	649,900,000	601,270,967 ( 92.52 %)	43,400,000 ( 6.678 %)	92.52 %

Name	Equities	%	Valuation
The Vanguard Group, Inc. 8.262 %	50,106,434	8.262 %	3 193 M $
AllianceBernstein LP 2.800 %	16,981,861	2.800 %	1 082 M $
Capital Research & Management Co. (Global Investors) 2.542 %	15,420,202	2.542 %	983 M $
Capital Research & Management Co. (World Investors) 2.099 %	12,733,292	2.099 %	811 M $
Wellington Management Co. LLP 2.066 %	12,530,027	2.066 %	798 M $
Geode Capital Management LLC 1.947 %	11,808,998	1.947 %	752 M $
Norges Bank Investment Management 1.455 %	8,824,423	1.455 %	562 M $
Union Investment Privatfonds GmbH 1.170 %	7,094,508	1.170 %	452 M $
Janus Henderson Investors US LLC 0.7133 %	4,326,167	0.7133 %	276 M $
Michael Mussallem 0.6666 %	4,042,863	0.6666 %	258 M $

Edwards Lifesciences Corp.

1209 Orange Street

19801, Wilmington

+949 250 2500

http://www.edwards.com

address Edwards Lifesciences Corporation(EW)

Name	Category and Sector
Edwards Lifesciences World Trade Corp.	Health Technology - Medical Specialties
Edwards Lifesciences Technology SARL	-
Edwards Lifesciences (India) Pvt Ltd.	Health Technology - Medical Specialties

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

69.49USD

Average target price

79.36USD

Spread / Average Target

+14.20%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EDWARDS LIFESCIENCES CORPORATION	-9.73%	42 146 M $
THERMO FISHER SCIENTIFIC	-10.05%	191 B $
DANAHER CORPORATION	-17.33%	163 B $
INTUITIVE SURGICAL, INC.	+16.66%	109 B $
BOSTON SCIENTIFIC CORPORATION	+18.39%	80 310 M $
SIEMENS HEALTHINEERS AG	+11.71%	63 346 M $
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-10.43%	47 620 M $
AGILENT TECHNOLOGIES, INC.	-13.40%	37 658 M $
GE HEALTHCARE TECHNOLOGIES INC.	+14.87%	30 979 M $
RESMED, INC.	-21.80%	24 121 M $

Other Advanced Medical Equipment & Technology